Unitil Reports Third Quarter Earnings
HAMPTON, N.H., Oct. 24, 2019 (GLOBE NEWSWIRE) — Unitil Corporation (NYSE: UTL) (www.unitil.com) today announced Net Income of $2.3 million, […]
GNC Holdings, Inc. Reports Third Quarter 2019 Results
Net loss of $2.4 million for the third quarter of 2019; Adjusted net income of $3.1 million, an increase of […]
Verizon Communications to report earnings October 25
NEW YORK, Oct. 24, 2019 (GLOBE NEWSWIRE) — Verizon Communications Inc. (NYSE, Nasdaq: VZ) will report third-quarter 2019 earnings on […]
Northrop Grumman Releases Third Quarter 2019 Financial Results
FALLS CHURCH, Va., Oct. 24, 2019 (GLOBE NEWSWIRE) — Northrop Grumman Corporation (NYSE: NOC) has released its third quarter 2019 […]
Brunswick Corporation Releases Third Quarter 2019 Earnings
Mettawa, Illinois, Oct. 24, 2019 (GLOBE NEWSWIRE) — Brunswick Corporation (NYSE: BC) today has released its third quarter 2019 financial […]
Cambrex Releases Selected Preliminary Third Quarter 2019 Financial Results
EAST RUTHERFORD, N.J., Oct. 24, 2019 (GLOBE NEWSWIRE) — Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug […]
Valero Energy Reports Third Quarter 2019 Results
Reported net income attributable to Valero stockholders of $609 million, or $1.48 per share.Invested $525 million of capital and completed the Central […]
BriaCell Announces Voting Results of the Special Meeting of Shareholders
BERKELEY, Calif. and VANCOUVER, British Columbia, Oct. 24, 2019 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (“BriaCell” or the “Company”) (TSX-V:BCT) […]
Wolverine World Wide Announces Third Quarter 2019 Conference Call for November 7, 2019
ROCKFORD, Mich., Oct. 24, 2019 (GLOBE NEWSWIRE) — Wolverine World Wide, Inc. (NYSE: WWW) today announced that it expects to […]
SpringWorks Therapeutics Announces Initiation of Phase 2b ReNeu Clinical Trial of Mirdametinib in Children and Adults with Neurofibromatosis Type 1 (NF1)-Associated Plexiform Neurofibromas (NF1-PN)
STAMFORD, Conn., Oct. 24, 2019 (GLOBE NEWSWIRE) — SpringWorks Therapeutics, Inc. (NASDAQ: SWTX), a clinical-stage biopharmaceutical company focused on developing […]
